A seizure is a sudden change in the brain's normal electrical activity. During a seizure, brain cells "fire" uncontrollably at up to four times their normal rate, temporarily affecting the way a ...

Q: My neighbor’s son was just diagnosed with KCNT1 seizures, and they said it was a very rare disorder. Aren’t seizures fairly common in children? A: The brain has many nerve cells that communicate ...

The International League Against Epilepsy (ILAE) has revised its classification of seizure types to improve nomenclature, add new seizure types, and give clinicians the ability to classify seizures ...

The sNDA submitted to support the monotherapy indication included clinical data involving over 2,400 adults with partial-onset seizures. The supplemental New Drug Application (sNDA) approval was based ...

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive ...

Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...

“It’s all about the brain,” said Jennifer DeWolfe, D.O., professor in the UAB Department of Neurology. “Seizure manifestations are stereotyped, so the same symptoms occur with each seizure that ...

Seizures have been described as irregular activity of the nerves in your brain, and sometimes these irregularities can become recurrent or chronic. When seizures become a consistent problem, this ...

MANY of the basic works in neurology comment on the rarity of seizures in chronic subdural hematoma. 1–3 Indeed, it is almost a maxim in many neurologic centers that the two are only rarely associated ...

Share on Pinterest A new drug reduced seizures in subjects with treatment resistant epilepsy in a recent clinical trial. The Good Brigade/Getty Images Researchers say a new medication may potentially ...

Last week, the FDA approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults. This approval will help offer additional aid for the many individuals throughout the world who live ...